'Staggeringly high' discontinuation rates for GLP-1 drugs like Ozempic or Wegovy

by Kristin Samuelson,Northwestern UniversityCredit: Markus Winkler from PexelsThe use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent yea

Updated on: November 29,2024 0

'Staggeringly high' discontinuation rates for GLP-1 drugs like Ozempic or Wegovy

by Kristin Samuelson,Northwestern UniversityCredit: Markus Winkler from PexelsThe use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent yea

Updated on:November 29,2024 0

Transient hypoglycemia worsens diabetic retinopathy via HIF-1a activation

Updated on: November 28,2024 0

Transient hypoglycemia worsens diabetic retinopathy via HIF-1a activation

Updated on:November 28,2024 0

Risk for mortality up with low income in type 2 diabetes

by Elana GotkineAdults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most prominent increase seen for adults aged 20 to 39 years, according t

Updated on: November 26,2024 0

Risk for mortality up with low income in type 2 diabetes

by Elana GotkineAdults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most prominent increase seen for adults aged 20 to 39 years, according t

Updated on:November 26,2024 0

Fat cells have epigenetics-based memory: Researchers discover mechanism behind weight loss yo-yo effect

by Fabio Bergamin,ETH ZurichHuman AT retains cellular transcriptional changes after BaS-induced WL. Credit:Nature(2024). DOI: 10.1038/s41586-024-08165-7Anyone who has ever tried to g

Updated on: November 24,2024 0

Fat cells have epigenetics-based memory: Researchers discover mechanism behind weight loss yo-yo effect

by Fabio Bergamin,ETH ZurichHuman AT retains cellular transcriptional changes after BaS-induced WL. Credit:Nature(2024). DOI: 10.1038/s41586-024-08165-7Anyone who has ever tried to g

Updated on:November 24,2024 0

The Persistent Memory of Fat: How Obesity Leaves a Lasting Epigenetic Imprint

Updated on: November 22,2024 0

The Persistent Memory of Fat: How Obesity Leaves a Lasting Epigenetic Imprint

Updated on:November 22,2024 0

Tirzepatide yields sustained weight reduction in obesity and prediabetes, finds study

by Elana GotkineFor patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according

Updated on: November 21,2024 0

Tirzepatide yields sustained weight reduction in obesity and prediabetes, finds study

by Elana GotkineFor patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according

Updated on:November 21,2024 0

Innovative islet transplant method reduces surgical complications for type 1 diabetes

by JooHyeon Heo,Ulsan National Institute of Science and TechnologySchematic and physical properties of bioprinted islet macroencapsulation system. Credit:Advanced Materials(2024). DO

Updated on: November 21,2024 0

Innovative islet transplant method reduces surgical complications for type 1 diabetes

by JooHyeon Heo,Ulsan National Institute of Science and TechnologySchematic and physical properties of bioprinted islet macroencapsulation system. Credit:Advanced Materials(2024). DO

Updated on:November 21,2024 0

Light-based therapy reduces pain associated with peripheral diabetic neuropathy, study concludes

Light-based therapy reduces pain associated with peripheral diabetic neuropathy, study concludesby Thais Szegö,FAPESPCredit: Unsplash/CC0 Public DomainA study conducted at the Federal University

Updated on: November 21,2024 0

Light-based therapy reduces pain associated with peripheral diabetic neuropathy, study concludes

Light-based therapy reduces pain associated with peripheral diabetic neuropathy, study concludesby Thais Szegö,FAPESPCredit: Unsplash/CC0 Public DomainA study conducted at the Federal University

Updated on:November 21,2024 0

Study: Eating more than 45% of calorie intake after 5 p.m. alters glucose levels, with serious consequences for health

by Teresa Bau and Sònia Armengou,Open University of CataloniaCredit:Nutrition & Diabetes(2024). DOI: 10.1038/s41387-024-00347-6Although people have always said that having a ligh

Updated on: November 21,2024 0

Study: Eating more than 45% of calorie intake after 5 p.m. alters glucose levels, with serious consequences for health

by Teresa Bau and Sònia Armengou,Open University of CataloniaCredit:Nutrition & Diabetes(2024). DOI: 10.1038/s41387-024-00347-6Although people have always said that having a ligh

Updated on:November 21,2024 0

Gum disease and diabetes: A strong link

by Ernie MundellPeriodontal (gum) disease and diabetes are locked in a grim partnership aimed at undermining your health, experts warn."Recent research has shown that diabetes is not only a major

Updated on: November 21,2024 0

Gum disease and diabetes: A strong link

by Ernie MundellPeriodontal (gum) disease and diabetes are locked in a grim partnership aimed at undermining your health, experts warn."Recent research has shown that diabetes is not only a major

Updated on:November 21,2024 0

Patients with diabetes are as satisfied with telehealth as with in-person care

by Jill Pease,University of FloridaReasons for using telehealth services among US adults with diabetes who used telehealth services in 2022, by modality. Credit:BMJ Open(2024). DOI:

Updated on: November 21,2024 0

Patients with diabetes are as satisfied with telehealth as with in-person care

by Jill Pease,University of FloridaReasons for using telehealth services among US adults with diabetes who used telehealth services in 2022, by modality. Credit:BMJ Open(2024). DOI:

Updated on:November 21,2024 0

GLP-1 RA use tied to lower rate of venous thromboembolism in diabetes

by Elana GotkineFor patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE), according t

Updated on: November 21,2024 0

GLP-1 RA use tied to lower rate of venous thromboembolism in diabetes

by Elana GotkineFor patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE), according t

Updated on:November 21,2024 0